Switzer TV

It's a weird one out there right now. As the resume of Trump tariffs looms large over the market, Peter Switzer and Paul Rickard look at everything from Telix (TLX) to ProMedicus (PME), Virgin (VGN) to Qantas (QAN), and explain why your ETFs and trusts might look a little weird right now on the charts.

 

 

 

Boom! Doom! Zoom! | 3 July 2025: Virgin, Qantas, Telix, Promedicus and more

It's a weird one out there right now. As the resume of Trump tariffs looms large over the market, Peter Switzer and Paul Rickard look at everything from Telix (TLX) to ProMedicus (PME), Virgin (VGN) to Qantas (QAN), and explain why your ETFs and trusts might look a little weird right now on the charts.

More videos

Getting real about the stock market sell off!

Peter Switzer catches up with Charlie Aitken, Paul Rickard, David Zammit and Russel Pillemer.

Series: ,
Sudden cardiac death in older people

Dr Ross Walker explains what makes sudden cardiac death in older people different.

Series: ,
Why we’re really MAD about money right now!

Peter Switzer and Paul Rickard discuss the latest market developments and what is making them really mad in the latest live episode of Mad about Money.

Series: ,
Stock market disaster? Or buying opportunity?

Following the worst day for the Australian sharemarket in over a decade, Peter Switzer speaks to Julia Lee, Michael McCarthy, Charlie Aitken, Paul Rickard and ST Wong to find out how they're responding.

Series: ,
Sudden cardiac death in young people

Dr Ross Walker explains what sudden cardiac death is and what you should do if you think you could be at risk.

Series: , ,
Mad about Money

Join Peter Switzer and Paul Rickard for this week's episode of Mad about Money. 

Series: ,
Coronavirus! Dr Doom Steve Keen & Chris Joye tell you how to play it

'Old debating enemies' Steve Keen and Chris Joye weigh in on the effects of COVID-19, plus Charlie Aitken and Paul Rickard.

Series: ,
James Garner from Kazia Therapeutics (KZA)

Peter Switzer speaks to Kazia Therepeutics (KZA) CEO James Garner about the company's work to develop a new drug for cancer.

Series: ,
Why vitamins may not be good for you

In this week's The Check Up, Dr Ross Walker explains why Vitamins may not be good for you.

Series: , ,
Dr Ron Weinberger from EMvision (EMV)

For an update on the company's progress in developing a portable brain scanner for detecting stroke, EMvision (ASX: EMV) CEO Dr Ron Weinberger joins Peter Switzer.

Series: ,
Bryce Crocker from Jervois Mining (JRV)

Peter Switzer is joined by Bryce Crocker, the CEO of mining and exploration company Jervois Mining (JRV).

Series: ,
Why vitamins don't always work

Why do some studies show no benefit for taking vitamins? Dr Ross Walker explains.

Series: ,

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram